Wells Fargo’s Virtus Biotech Clinical Trials ETF BBC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-322
Closed -$6.32K – 7590
2023
Q3
$6.32K Buy
+322
New +$7.15K ﹤0.01% 5920
2022
Q2
– Sell
-225
Closed -$6K – 6792
2022
Q1
$6K Hold
225
– – ﹤0.01% 6412
2021
Q4
$9K Hold
225
– – ﹤0.01% 6568
2021
Q3
$10K Hold
225
– – ﹤0.01% 6194
2021
Q2
$11K Sell
225
-154
-41% -$7.54K ﹤0.01% 6105
2021
Q1
$19K Sell
379
-691
-65% -$37.8K ﹤0.01% 6166
2020
Q4
$53K Hold
1,070
– – ﹤0.01% 5567
2020
Q3
$42K Buy
1,070
+845
+376% +$34.4K ﹤0.01% 5571
2020
Q2
$10K Hold
225
– – ﹤0.01% 5840
2020
Q1
$7K Hold
225
– – ﹤0.01% 5797
2019
Q4
$9K Hold
225
– – ﹤0.01% 5911
2019
Q3
$5K Sell
225
-729
-76% -$19.8K ﹤0.01% 6053
2019
Q2
$27K Sell
954
-25
-3% -$698 ﹤0.01% 5724
2019
Q1
$27K Buy
979
+25
+3% +$655 ﹤0.01% 5451
2018
Q4
$22K Buy
954
+225
+31% +$6.14K ﹤0.01% 5756
2018
Q3
$25K Hold
729
– – ﹤0.01% 5771
2018
Q2
$24K Hold
729
– – ﹤0.01% 5778
2018
Q1
$24K Hold
729
– – ﹤0.01% 5765
2017
Q4
$21K Hold
729
– – ﹤0.01% 5784
2017
Q3
$21K Hold
729
– – ﹤0.01% 5697
2017
Q2
$18K Hold
729
– – ﹤0.01% 5646
2017
Q1
$17K Hold
729
– – ﹤0.01% 5744
2016
Q4
$13K Buy
+729
New +$14.5K ﹤0.01% 5728

Other funds holding BBC

Wells Fargo's BBC Position: Q4 2023 in Review

Wells Fargo sold out of Virtus Biotech Clinical Trials ETF (BBC) in Q4 2023, closing a stake of 322 shares — an estimated $6.32K sold.

Wells Fargo first reported a position in BBC in Q4 2016 and held it in 23 quarters. The position peaked at $53K in Q4 2020. 18 funds tracked by Wall St. Rank hold BBC as of Q4 2023.

  • Wells Fargo reported no remaining Virtus Biotech Clinical Trials ETF position as of Q4 2023 after selling out during the quarter.
  • Wells Fargo sold 322 Virtus Biotech Clinical Trials ETF shares in Q4 2023, an estimated $6.32K.
  • Wells Fargo first reported a position in Virtus Biotech Clinical Trials ETF in Q4 2016 and held it in 23 quarters.
  • Wells Fargo's Virtus Biotech Clinical Trials ETF position peaked at $53K in Q4 2020.
  • 18 funds tracked by Wall St. Rank held Virtus Biotech Clinical Trials ETF as of Q4 2023.

Based on Wells Fargo's 13F filing for Q4 2023, filed 9 Feb 2024.